CYCN vs VRTX: Which Stock is Better?
Side-by-side comparison of Cyclerion Therapeutics Inc and Vertex Pharmaceuticals Inc in 2026
CYCN
Cyclerion Therapeutics Inc
$1.35
VRTX
Vertex Pharmaceuticals Inc
$442.08
Key Metrics Comparison
| Metric | CYCN | VRTX | Winner |
|---|---|---|---|
| Market Cap | $5.14M | $113.35B | VRTX |
| P/E Ratio | N/A | 31.15 | VRTX |
| EPS (TTM) | $N/A | $14.19 | VRTX |
| Revenue Growth | 3.5% | 0.1% | CYCN |
| Gross Margin | 92.6% | 52.7% | CYCN |
Analyze CYCN
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CYCN or VRTX a better investment?
Comparing CYCN and VRTX: Cyclerion Therapeutics Inc has a market cap of $5.14M while Vertex Pharmaceuticals Inc has $113.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CYCN and VRTX?
CYCN (Cyclerion Therapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CYCN or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CYCN or VRTX?
CYCN has higher revenue growth at 3.5% vs 0.1% for VRTX.
Which company is more profitable: CYCN or VRTX?
Cyclerion Therapeutics Inc (CYCN) has higher gross margins at 92.6% compared to 52.7% for VRTX.
Which is the larger company: CYCN or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.35B compared to $5.14M for CYCN.
Should I buy CYCN or VRTX in 2026?
Both CYCN and VRTX have investment merit. CYCN trades at $1.35 while VRTX trades at $442.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CYCN and VRTX stock?
Key differences: Market Cap ($5.14M vs $113.35B), P/E Ratio (N/A vs 31.2x), Revenue Growth (3.5% vs 0.1%), Gross Margin (92.6% vs 52.7%).